GIPR selective agonist Therapy(Structure Therapeutics)

N/A

Report date: 2026/04/08 20:02:35

Base Information

Drug NameGIPR selective agonist Therapy(Structure Therapeutics)
Drug Alias NameNext Gen GSBR (Structure Therapeutics)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlucagon-like peptide 1 receptor agonistsGlucose-Dependent Insulinotropic Polypeptide Receptor agonists
TargetsGlucagon-like peptide 1 receptorGlucose-Dependent Insulinotropic Polypeptide Receptor
Therapy Area/IndicationsObesityDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesStructure Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesStructure Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsObesityDiabetes Mellitus, Type 2
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A